drugset / Trial / NCT07606833
The Clinical Trail to Evaluate the Efficacy and Safety of Anaprazole Sodium Enteric-coated Tablets Combined With Bismuth-containing Quadruple Therapy in Eradicating Helicobacter Pylori
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a multicenter, randomized, double blind, double-simulated, parallel control of positive drug phase III clinical study to evaluate the efficacy and safety of Anaprazole versus Esomeprazole-containing Bismuth quadruple therapy for eradication of Helicobacter pylori in China.
Timeline
- Start
- 2026-06-10
- Primary completion
- 2027-02-19
- Completion
- 2027-03-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anaprazole | Other / unclassified | 20 mg | Oral |
| Comparator | Esomeprazole | Small molecule | 20 mg | Oral |
| Background | Amoxicillin | Other / unclassified | 1000 mg | Oral |
| Background | Bismuth Potassium Citrate | Unknown | 240 mg | Oral |
| Background | Clarithromycin | Small molecule | 500 mg | Oral |